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Background
Glucose starvation, as occurs in neoplastic tumors, causes
G1 arrest and/or apoptosis. Although the mechanisms for
these events are poorly understood, reductions in nucleo-
tide synthesis and ATP are widely believed to restrict
progression into the S phase and cause apoptosis, respec-
tively. Recently, a side product of glycolysis and stimula-
tor of PFK-1, fructose 2,6-bisphosphate (F2,6BP), was
found to be synthesized in the nucleus of cells by the
enzyme PFKFB3 and to stimulate proliferation in part by
activating cyclin dependent kinases (Cdk). We hypothe-
sized that glucose deprivation would reduce F2,6BP
which in turn would suppress the activity of Cdks and
cause G1 arrest and apoptosis.
Materials and methods
Methods included: (i) Western blot for PFKFB3 expression
in the cytoplasm and nuclei of A549 cells; (ii) transfection
with PFKFB3 siRNA and examination of F2,6BP, Cdk1
activity, p27 expression, cell cycle and apoptosis; (iii) cell
cycle analysis after PFKFB3 over-expression; (iv) measure-
ment of recombinant Cdk1, CDC25A-C and Wee1 activ-
ities after exposure to F2,6BP; (v) determination of the
requirement of multiple regulators of the cell cycle on the
proliferative effect of PFKFB3; and (vi) quantification of
the effects of glucose deprivation on F2,6BP and the
CDC25B substrate phospho-Y15-Cdk1.
Results
In unpublished results, we demonstrate that: (i) PFKFB3
is selectively expressed in the nucleus during the regula-
tory G2, M and G1 phases of the cell cycle and in the
cytoplasm during the S phase (when glycolysis and DNA
synthesis occur); (ii) selection inhibition of PFKFB3
reduces F2,6BP which in turn suppresses Cdk1 activity,
increases the Cdk inhibitor p27 and causes a G1/S block
and apoptosis; (iii) over-expression of PFKFB3 accelerates
G1/S transition; (iv) F2,6BP directly stimulates the activ-
ity of recombinant CDC25B which dephosphorylates Y15
in the ATP binding domain of Cdk1 causing activation;
(v) selective inhibition of CDC25B or Cdk1 reverses the
proliferative effect caused by over-expression of nuclear
PFKFB3; and (vi) glucose deprivation reduces F2,6BP and
CDC25 activity within 1 hour as determined by increased
phospho-Y15-Cdk1 (the dephosphorylation site of
CDC25B).
Conclusions
We conclude that F2,6BP acts as a glucose sensor that reg-
ulates survival and cell cycle progression by activating
CDC25B during the G1 phase and glucose metabolism by
activating PFK-1 during the S phase of the cell cycle. A
novel PFKFB3 inhibitor, PFK158, has entered phase I trials
and we anticipate that these data will help to develop
rational combinations of PFKFB3 inhibitors with other
targeted therapies for testing in phase I/II trials.
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